What Now for Residential Construction? The Housing Industry Post-Pandemic
The COVID-19 pandemic is essentially over, but the disruption to the housing industry that lies in its wake will be felt for years to come
Source: probuilder.com
Data From News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Data From. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Data From Today - Breaking & Trending Today
Genmab A/S: Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
Preliminary analysis of data from the EPCORE NHL-2 study demonstrates patients with previously untreated follicular lymphoma (FL) who received epcoritamab in combination with rituximab-lenalidomide
Source: finanznachrichten.de
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
02.06.2024 - Genmab A/S (Nasdaq: GMAB) today announced new efficacy and safety data from two ongoing Phase 1/2 clinical trials evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, in adult patients with certain types of ...
Source: wallstreet-online.de
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting | Region
FOSTER CITY, Calif.--(BUSINESS WIRE)--May 18, 2024--
Source: eagletribune.com
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting
- Seven abstracts highlighting ALGS and PFIC data, including three oral presentations - Long-term extension data from Phase 3 MARCH-ON PFIC study presented at plenary session and selected among the...
Source: marketscreener.com